Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Understanding the importance of cerebrovascular involvement in Kawasaki disease

  • Yeom, Jung Sook (Department of Pediatrics, Gyeongsang National University Hospital, Gyeongsang Institute of Health Science, Gyeongsang National University College of Medicine) ;
  • Cho, Jae Young (Department of Pediatrics, Gyeongsang National University Hospital, Gyeongsang Institute of Health Science, Gyeongsang National University College of Medicine) ;
  • Woo, Hyang-Ok (Department of Pediatrics, Gyeongsang National University Hospital, Gyeongsang Institute of Health Science, Gyeongsang National University College of Medicine)
  • Received : 2019.02.13
  • Accepted : 2019.05.15
  • Published : 2019.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Kawasaki disease (KD) is a systemic vasculitis in infants and young children. However, its natural history has not been fully elucidated because the first case was reported in the late 1960s and patients who have recovered are just now entering middle age. Nevertheless, much evidence has raised concerns regarding the subclinical vascular changes that occur in post-KD patients. KD research has focused on coronary artery aneurysms because they are directly associated with fatality. However, aneurysms have been reported in other extracardiac muscular arteries and their fate seems to resemble that of coronary artery aneurysms. Arterial strokes in KD cases are rarely reported. Asymptomatic ischemic lesions were observed in a prospective study of brain vascular lesions in KD patients with coronary artery aneurysms. The findings of a study of single-photon emission computed tomography suggested that asymptomatic cerebral vasculitis is more common than we believed. Some authors assumed that the need to consider the possibility of brain vascular lesions in severe cases of KD regardless of presence or absence of neurological symptoms. These findings suggest that KD is related with cerebrovascular lesions in children and young adults. Considering the fatal consequences of cerebral vascular involvement in KD patients, increased attention is required. Here we review our understanding of brain vascular involvement in KD.

Keywords

References

  1. Landing BH, Larson EJ. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol 1987;1:218-29.
  2. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. https://doi.org/10.1161/01.CIR.94.6.1379
  3. Newburger JW. Treatment of Kawasaki disease. Lancet 1996;347:1128. https://doi.org/10.1016/S0140-6736(96)90600-5
  4. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7. https://doi.org/10.1056/NEJM198608073150601
  5. Hoshino S, Tsuda E, Yamada O. Characteristics and fate of systemic artery aneurysm after Kawasaki disease. J Pediatr 2015;167:108,12.e1-2. https://doi.org/10.1016/j.jpeds.2015.04.036
  6. Sabatier I, Chabrier S, Brun A, Hees L, Cheylus A, Gollub R, et al. Stroke by carotid artery complete occlusion in Kawasaki disease: Case report and review of literature. Pediatr Neurol 2013;49:469-73. https://doi.org/10.1016/j.pediatrneurol.2013.08.011
  7. Amano S, Hazama F. Neutral involvement in Kawasaki disease. Acta Pathol Jpn 1980;30:365-73.
  8. Dietz SM, Tacke CE, Gort J, Kuipers IM, de Groot E, Wiegman A, et al. Carotid intima-media thickness in patients with a history of Kawasaki disease. Circ J 2015;79:2682-7. https://doi.org/10.1253/circj.CJ-15-0555
  9. Hosaki J, Abe S, Shoback BR, Yoshimatu A, Migita T. Mucocutaneous lymph node syndrome with various arterial lesions. Helv Paediatr Acta 1978;33:127-33.
  10. Laxer RM, Dunn HG, Flodmark O. Acute hemiplegia in Kawasaki disease and infantile polyarteritis nodosa. Dev Med Child Neurol 1984;26:814-8. https://doi.org/10.1111/j.1469-8749.1984.tb08176.x
  11. Templeton PA, Dunne MG. Kawasaki syndrome: cerebral and cardiovascular complications. J Clin Ultrasound 1987;15:483-5. https://doi.org/10.1002/jcu.1870150711
  12. Suda K, Matsumura M, Ohta S. Kawasaki disease complicated by cerebral infarction. Cardiol Young 2003;13:103-5. https://doi.org/10.1017/S1047951103000179
  13. Wada Y, Kamei A, Fujii Y, Ishikawa K, Chida S. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. J Pediatr 2006;148:399-400. https://doi.org/10.1016/j.jpeds.2005.10.027
  14. Fujiwara S, Yamano T, Hattori M, Fujiseki Y, Shimada M. Asymptomatic cerebral infarction in Kawasaki disease. Pediatrc Neurol 1992;8:235-6. https://doi.org/10.1016/0887-8994(92)90077-C
  15. Muneuchi J, Kusuhara K, Kanaya Y, Ohno T, Furuno K, Kira R, et al. Magnetic resonance studies of brain lesions in patients with Kawasaki disease. Brain Dev 2006;28:30-3. https://doi.org/10.1016/j.braindev.2005.04.003
  16. Tassinari D, Maretti M, Balsamo C, Bergamsschi R, Carfagnini F, Fabi M, et al. Acute hemiplegia and facial palsy 4-months after acute Kawasaki disease in a 31-month old girl. JSM Clin Case Rep 2014;2:1017.
  17. Prangwatanagul W, Limsuwan A. Ischemic stroke in Kawasaki disease. Pediatr Int 2017;59:92-6. https://doi.org/10.1111/ped.13170
  18. Nikkhah A. Atypical Kawasaki disease presenting with hemiparesis and aphasia: a case report. Iran J Med Sci 2018;43:86-9.
  19. Gitiaux C, Kossorotoff M, Bergounioux J, Adjadj E, Lesage F, Boddaert N, et al. Cerebral vasculitis in severe Kawasaki disease: early detection by magnetic resonance imaging and good outcome after intensive treatment. Dev Med Child Neurol 2012;54:1160-3. https://doi.org/10.1111/dmcn.12002
  20. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology 1998;50:341-50. https://doi.org/10.1212/WNL.50.2.341
  21. Boespflug O, Tardieu M, Losay J, Leroy D. Acute hemiplegia complicating Kawasaki disease. Rev Neurol (Paris) 1984;140:507-9.
  22. Guo Y, Tian X, Wang X, Xiao Z. Adverse effects of immunoglobulin therapy. Front Immunol 2018;9:1299. https://doi.org/10.3389/fimmu.2018.01299
  23. Lapointe JS, Nugent RA, Graeb DA, Robertson WD. Cerebral infarction and regression of widespread aneurysms in Kawasaki's disease: case report. Pediatr Radiol 1984;14:1-5. https://doi.org/10.1007/BF02386720
  24. Tanaka S, Sagiuchi T, Kobayashi I. Ruptured pediatric posterior cerebral artery aneurysm 9 years after the onset of Kawasaki disease: a case report. Childs Nerv Syst 2007;23:701-6. https://doi.org/10.1007/s00381-006-0263-8
  25. Ahn JH, Phi JH, Kang HS, Wang KC, Cho BK, Lee JY, et al. A ruptured middle cerebral artery aneurysm in a 13-month-old boy with Kawasaki disease. J Neurosurg Pediatr 2010;6:150-3. https://doi.org/10.3171/2010.5.PEDS1012
  26. Ishida A, Matsuo S, Kawamura S, Nishikawa T. Subarachnoid hemorrhage due to nonbranching aneurysm of the middle cerebral artery in a young adult with a history of Kawasaki disease. Surg Neurol Int 2014;5:5,7806.125285. eCollection 2014. https://doi.org/10.4103/2152-7806.125285
  27. Du ZD, Wang Q, Liu XY. Intracranial hemorrhage in children in the acute stage of Kawasaki disease. Zhonghua Er Ke Za Zhi 2005;43:542-3.
  28. Yamazaki-Nakashimada MA, Rivas-Larrauri F, Alcantara-Salinas A, Hernandez-Bautista V, Rodriguez-Lozano AL. Brain hemorrhage in a patient with Kawasaki disease. Rev Alerg Mex 2013;60:38-40.
  29. Ichiyama T, Nishikawa M, Hayashi T, Koga M, Tashiro N, Furukawa S. Cerebral hypoperfusion during acute Kawasaki disease. Stroke 1998;29:1320-1. https://doi.org/10.1161/01.STR.29.7.1320
  30. Meusser S, Rubbert A, Manger B, Bock E, Platsch G, Feistel H, et al. 99m-tc-HMPAO-SPECT in diagnosis of early cerebral vasculitis. Rheumatol Int 1996;16:37-42. https://doi.org/10.1007/BF01419953
  31. Yeom JS, Cho YH, Koo CM, Jun JS, Park JS, Park ES, et al. A pilot study evaluating cerebral vasculitis in Kawasaki's disease. Neuropediatrics 2018;49:392-6. https://doi.org/10.1055/s-0038-1660855
  32. Hirohata S, Tanimoto K, Ito K. Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement. Clin Immunol Immunopathol 1993;66:225-9. https://doi.org/10.1006/clin.1993.1029
  33. Salvarani C, Brown RD Jr, Calamia KT, Huston J 3rd, Meschia JF, Giannini C, et al. Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment. Arthritis Rheum 2008;59:291-6. https://doi.org/10.1002/art.23337
  34. Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis 2010;3:173-81. https://doi.org/10.3400/avd.sasvp01003
  35. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 2001;44:2841-50. https://doi.org/10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6
  36. Ogihara Y, Ogata S, Nomoto K, Ebato T, Sato K, Kokubo K, et al. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance. Pediatr Res 2014;76:287-93. https://doi.org/10.1038/pr.2014.92
  37. Carrizzo A, Lenzi P, Procaccini C, Damato A, Biagioni F, Ambrosio M, et al. Pentraxin 3 induces vascular endothelial dysfunction through a P-selectin/matrix metalloproteinase-1 pathway. Circulation 2015;131:1495,505; discussion 1505. https://doi.org/10.1161/CIRCULATIONAHA.114.014822
  38. Korematsu S, Uchiyama S, Miyahara H, Nagakura T, Okazaki N, Kawano T, et al. The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki disease. Pediatr Infect Dis J 2007;26:750-3. https://doi.org/10.1097/INF.0b013e3180f61708
  39. Dietz SM, Tacke CE, de Groot E, Kuipers IM, Hutten BA, Kuijpers TW, et al. Extracardial vasculopathy after Kawasaki disease: a long-term follow-up study. J Am Heart Assoc 2016;5(7). pii: e003414. https://doi.org/10.1161/JAHA.116.003414.

Cited by

  1. Brainstem Auditory Evoked Potentials and Visual Potentials in Kawasaki Disease: An Observational Monocentric Study vol.8, 2019, https://doi.org/10.3389/fped.2020.581780
  2. Neurological involvement in Kawasaki disease: a retrospective study vol.18, pp.1, 2019, https://doi.org/10.1186/s12969-020-00452-7
  3. Kawasaki Disease Complicated by Late-Onset Fatal Cerebral Infarction: A Case Report and Literature Review vol.9, 2019, https://doi.org/10.3389/fped.2021.598867
  4. Case Report: Kawasaki Shock Syndrome With Polycyclic Eruption: A Peculiar Brain Imaging vol.9, 2019, https://doi.org/10.3389/fped.2021.651457
  5. Long-term hearing and neurodevelopmental outcomes following Kawasaki disease: A population-based cohort study vol.43, pp.7, 2019, https://doi.org/10.1016/j.braindev.2021.03.001